Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Electrocardiol ; 50(6): 769-775, 2017.
Article in English | MEDLINE | ID: mdl-29021091

ABSTRACT

Interest in the effects of drugs on the heart rate-corrected JTpeak (JTpc) interval from the body-surface ECG has spawned an increasing number of scientific investigations in the field of regulatory sciences, and more specifically in the context of the Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative. We conducted a novel initiative to evaluate the role of automatic JTpc measurement technologies by comparing their ability to distinguish multi- from single-channel blocking drugs. A set of 5232 ECGs was shared by the FDA (through the Telemetric and Holter ECG Warehouse) with 3 ECG device companies (AMPS, Mortara, and Philips). We evaluated the differences in drug-concentration effects on these measurements between the commercial and the FDA technologies. We provide a description of the drug-induced placebo-corrected changes from baseline for dofetilide, quinidine, ranolazine, and verapamil, and discuss the various differences across all technologies. The results revealed only small differences between measurement technologies evaluated in this study. It also confirms that, in this dataset, the JTpc interval distinguishes between multi- and single-channel (hERG) blocking drugs when evaluating the effects of dofetilide, quinidine, ranolazine, and verapamil. However, in the case of quinidine and dofetilide, we noticed a poor consistency across technologies because of the lack of standard definitions for the location of the peak of the T-wave (T-apex) when the T-wave morphology is abnormal.


Subject(s)
Algorithms , Biomarkers/analysis , Electrocardiography, Ambulatory/methods , Heart Conduction System/drug effects , Ion Channels/drug effects , Long QT Syndrome/chemically induced , Potassium Channel Blockers/pharmacology , Sodium Channel Blockers/pharmacology , Torsades de Pointes/chemically induced , Adolescent , Adult , Healthy Volunteers , Humans , Phenethylamines/pharmacology , Quinidine/pharmacology , Ranolazine/pharmacology , Sulfonamides/pharmacology , Verapamil/pharmacology
2.
J Electrocardiol ; 45(6): 561-5, 2012.
Article in English | MEDLINE | ID: mdl-22995382

ABSTRACT

BACKGROUND: Interpretation of a patient's 12-lead ECG frequently involves comparison to a previously recorded ECG. Automated serial ECG comparison can be helpful not only to note significant ECG changes but also to improve the single-ECG interpretation. Corrections from the previous ECG are carried forward by the serial comparison algorithm when measurements do not change significantly. METHODS: A sample of patients from three hospitals was collected with two or more 12-lead ECGs from each patient. There were 233 serial comparisons from 143 patients. 41% of patients had two ECGs and 59% of patients had more than two ECGs. ECGs were taken from a difficult population as measured by ECG abnormalities, 197/233 abnormal, 11/233 borderline, 14/233 otherwise-normal and 11/233 normal. ECGs were processed with the Philips DXL algorithm and then in time order for each patient with the Philips serial comparison algorithm. To measure accuracy of interpretation and serial change, an expert cardiologist corrected the ECGs in stages. The first ECG was corrected and used as the reference for the second ECG. The second ECG was then corrected and used as the reference for the third ECG and so on. At each stage, the serial comparison algorithm compared an unedited ECG to an earlier edited ECG. Interpretation accuracy was measured by comparing the algorithm to the cardiologist on a statement by statement basis. The effect of serial comparison was measured by the sum of interpretive statement mismatches between the algorithm and cardiologist. Statement mismatches were measured in two ways, (1) exact match and (2) match within the same diagnostic category. RESULTS: The cardiologist used 910 statements over 233 ECGs for an average number of 3.9 statements per ECG and a mode of 4 statements. When automated serial comparison was used, the total number of exact statement mismatches decreased by 29% and the total same-category statement mismatches decreased by 47%. CONCLUSION: Automated serial comparison improves interpretation accuracy in addition to its main role of noting differences between ECGs.


Subject(s)
Algorithms , Arrhythmias, Cardiac/diagnosis , Artificial Intelligence , Diagnosis, Computer-Assisted/methods , Electrocardiography/methods , Pattern Recognition, Automated/methods , Humans , Reproducibility of Results , Sensitivity and Specificity
3.
J Electrocardiol ; 45(4): 343-9, 2012.
Article in English | MEDLINE | ID: mdl-22912955

ABSTRACT

BACKGROUND: Classifying the location of an occlusion in the culprit artery during ST-elevation myocardial infarction (STEMI) is important for risk stratification to optimize treatment. We developed a new logistic regression (LR) algorithm for 3-group classification of occlusion location as proximal right coronary artery (RCA), middle-to-distal RCA or left circumflex (LCx) coronary artery with inferior myocardial infarction. We compared the performance of the new LR algorithm with the recently introduced decision tree classifier of Fiol et al (Ann Noninvasive Electrocardiol. 2004;4:383-388) in the classification of the same 3 categories. METHODS: The new algorithm was developed on a set of electrocardiograms from an emergency department setting (n = 64) and tested on a different set from a prehospital setting (n = 68). All patients met the current STEMI criteria with angiographic confirmation of culprit artery and occlusion location. Using LR, 4 ST-segment deviation features were chosen by forward stepwise selection. Final LR coefficients were obtained by averaging more than 200 bootstrap iterations on the training set. In addition, a separate 4-feature classifier was designed adding ST features of V4R and V8, only available in the training set. RESULTS: The LR algorithm classified proximal RCA occlusion vs combined LCx occlusion and middle-to-distal RCA occlusion, with a sensitivity of 76% and specificity of 81% as compared with 71% and 62% for the Fiol classifier. The difference in specificity was statistically significant. The LR classifier trained with additional ST features of V4R and V8, but still limited to 4, improved the overall agreement in the training set from 65% to 70%. CONCLUSION: Discrimination of proximal RCA lesion location from LCx or middle-to-distal RCA using the new LR classifier shows improvement over decision tree­type classification criteria. Automated identification of proximal RCA occlusion could speed up the risk stratification of patients with STEMI. The addition of leads V4R and V8 should further improve the automated classification of the occlusion site in RCA and LCx.


Subject(s)
Coronary Occlusion/diagnosis , Electrocardiography , Myocardial Infarction/diagnosis , Adult , Aged , Aged, 80 and over , Algorithms , Coronary Angiography , Coronary Occlusion/complications , Coronary Occlusion/diagnostic imaging , Coronary Occlusion/pathology , Female , Humans , Logistic Models , Male , Middle Aged , Myocardial Infarction/complications , Myocardial Infarction/diagnostic imaging , Predictive Value of Tests , Sensitivity and Specificity
4.
J Electrocardiol ; 45(4): 343-349, 2012.
Article in English | MEDLINE | ID: mdl-32155693

ABSTRACT

BACKGROUND: Classifying the location of an occlusion in the culprit artery during ST-elevation myocardial infarction (STEMI) is important for risk stratification to optimize treatment. We developed a new logistic regression (LR) algorithm for 3-group classification of occlusion location as proximal right coronary artery (RCA), middle-to-distal RCA or left circumflex (LCx) coronary artery with inferior myocardial infarction. We compared the performance of the new LR algorithm with the recently introduced decision tree classifier of Fiol et al (Ann Noninvasive Electrocardiol. 2004;4:383-388) in the classification of the same 3 categories. METHODS: The new algorithm was developed on a set of electrocardiograms from an emergency department setting (n = 64) and tested on a different set from a prehospital setting (n = 68). All patients met the current STEMI criteria with angiographic confirmation of culprit artery and occlusion location. Using LR, 4 ST-segment deviation features were chosen by forward stepwise selection. Final LR coefficients were obtained by averaging more than 200 bootstrap iterations on the training set. In addition, a separate 4-feature classifier was designed adding ST features of V4R and V8, only available in the training set. RESULTS: The LR algorithm classified proximal RCA occlusion vs combined LCx occlusion and middle-to-distal RCA occlusion, with a sensitivity of 76% and specificity of 81% as compared with 71% and 62% for the Fiol classifier. The difference in specificity was statistically significant. The LR classifier trained with additional ST features of V4R and V8, but still limited to 4, improved the overall agreement in the training set from 65% to 70%. CONCLUSION: Discrimination of proximal RCA lesion location from LCx or middle-to-distal RCA using the new LR classifier shows improvement over decision tree-type classification criteria. Automated identification of proximal RCA occlusion could speed up the risk stratification of patients with STEMI. The addition of leads V4R and V8 should further improve the automated classification of the occlusion site in RCA and LCx.

SELECTION OF CITATIONS
SEARCH DETAIL
...